The following is a summary of “Survival outcomes of primary vs interval cytoreductive surgery for International Federation of Gynecology and Obstetrics stage IV ovarian cancer: a nationwide population ...
Cytoreductive nephrectomy (CN) of the primary tumor in the face of metastatic disease is part of a multimodality approach including systemic therapy that is based on evidence from randomized ...
The guideline authors used data from 61 studies to provide recommendations on the use of neoadjuvant chemotherapy in patients with newly diagnosed, stage III-IV epithelial ovarian, fallopian tube, or ...
The benefits of HIPEC include improved local control of cancer, reduced recurrence rates, and enhanced survival outcomes for ...
How a radical surgical approach saved the life of a neonatal nurse practitioner with a rare abdominal cancer - but meant ...
5 天
Asian News International on MSNUnited by Unique: Expert Advice on Personalized Cancer Care for World Cancer Day 2025On World Cancer Day, we come together to reflect on the progress made in the fight against cancer and the importance of ...
However, solid tumors continue to pose unique therapeutic challenges, and the conventional cytoreductive therapies have proven to be of limited efficacy. NK cell based therapeutic strategies have been ...
Chandigarh resident, Rashmi Bindra, was first got diagnosed on April 26, 2017 with breast cancer in advanced third stage when ...
Service specifications are important in clearly defining the standards of care expected from organisations funded by NHS England to provide specialised care. The specifications have been developed by ...
FDA Accepts Nivolumab Subcutaneous Injection Application, With Potential to Boost Access to PD-1 Inhibitors ...
More than half of all patients with colorectal cancer (CRC) develop distant metastasis and, depending on the local stage of the primary tumor, up to 48% of patients present peritoneal carcinomatosis ...
Overexpression of PLCG2 and TMEM38A inhibit tumor progression in clear cell renal cell carcinoma. February 7, 2025 New Mediastinal and Hilar Lymphadenopathy After Adjuvant Pembrolizumab in a Patient ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果